EVIO Inc (EVIO)

[StevenRisk]

The toxic note was converted plus the 8% interest which I believe was all converted to stock also with a 45% discount. I agree somewhat with what you have said but the fact remains revenues were slightly up which still means the plan is intact. The increased losses are solely attributed to in-house which was $256K per Q not to mention added expenses which of course IMO along with added revenues beyond the $256K due to convenience and timliness. Testing part of the product and then sending it out obviously is timely and these growers want results ASAP.

FWIW, I did vote against #2 as any R/S IMO should be proportionate to A/S also as it gives to much discretion to management and the fact we are not compliant with outside directors and other short coming financially certainly can not be overlooked. The problem when using dilution for acquisitions being revenues must match the dilution proportionately otherwise common shareholders get squeezed again. Had anagement been compliant I would not have voted this way as we would have had more seasoned business people making these decisions. Of course IMO.